Head-To-Head Review: Evolent Health (EVH) & Tabula Rasa Healthcare (TRHC)
Evolent Health (NYSE: EVH) and Tabula Rasa Healthcare (NASDAQ:TRHC) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.
Insider & Institutional Ownership
68.1% of Evolent Health shares are owned by institutional investors. Comparatively, 25.3% of Tabula Rasa Healthcare shares are owned by institutional investors. 8.8% of Evolent Health shares are owned by insiders. Comparatively, 45.8% of Tabula Rasa Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Evolent Health and Tabula Rasa Healthcare’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Evolent Health||$361.53 million||3.15||-$51.15 million||($1.21)||-14.30|
|Tabula Rasa Healthcare||$108.83 million||3.15||$2.26 million||($0.74)||-26.82|
Tabula Rasa Healthcare has higher revenue, but lower earnings than Evolent Health. Tabula Rasa Healthcare is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings for Evolent Health and Tabula Rasa Healthcare, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Tabula Rasa Healthcare||0||0||5||0||3.00|
Evolent Health presently has a consensus price target of $30.33, suggesting a potential upside of 75.34%. Tabula Rasa Healthcare has a consensus price target of $18.75, suggesting a potential downside of 5.54%. Given Evolent Health’s stronger consensus rating and higher possible upside, research analysts plainly believe Evolent Health is more favorable than Tabula Rasa Healthcare.
This table compares Evolent Health and Tabula Rasa Healthcare’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Tabula Rasa Healthcare||-10.27%||-9.58%||-4.51%|
Evolent Health beats Tabula Rasa Healthcare on 7 of the 13 factors compared between the two stocks.
Evolent Health Company Profile
Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company’s services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company’s technology platform that aggregates and analyzes data, manages care workflows and engages patients.
Tabula Rasa Healthcare Company Profile
Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.
Receive News & Ratings for Evolent Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.